Mirum Pharmaceuticals, Inc.
MIRM
$67.72
-$2.37-3.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 149.56% | 60.07% | 38.31% | -67.12% | 42.22% |
| Total Depreciation and Amortization | 0.10% | 0.07% | -18.33% | 22.38% | 3.43% |
| Total Amortization of Deferred Charges | 3.75% | -1.39% | 4.09% | -1.89% | 4.18% |
| Total Other Non-Cash Items | 0.85% | 2.54% | 39.35% | -3.04% | -0.30% |
| Change in Net Operating Assets | 285.25% | 41.97% | -571.64% | -36.53% | -178.82% |
| Cash from Operations | 229.58% | 713.97% | 61.31% | -227.21% | 204.76% |
| Capital Expenditure | -48.41% | -207.32% | -105.00% | 88.95% | 76.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.48% | 59.78% | -2,534.64% | 103.70% | 75.18% |
| Cash from Investing | 66.25% | 59.10% | -2,617.00% | 103.55% | 75.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 85.27% | 36.63% | 19.08% | 38.23% | -47.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.27% | 36.63% | 19.08% | 38.23% | -47.02% |
| Foreign Exchange rate Adjustments | -84.32% | 111.00% | 176.50% | -1,667.05% | 173.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 229.56% | 253.12% | -2,192.06% | 95.39% | 85.43% |